• Ownership

David Hallal - Insider Trading & Ownership

Entity
Individual
Location
C/O Alexion Pharmaceuticals, Inc, 352 Knotter Drive, Cheshire, CT
Summary
The estimated net worth of David Hallal is at least $19M dollars as of April 11, 2025. David Hallal is the Director of Kalaris Therapeutics, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $15.6M. David Hallal is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $2.73M. David Hallal is the Director of Seer, Inc. and owns shares of Seer, Inc. (SEER) stock worth about $722K.
All Insider Reports
All Insider Reports

Ownership of David Hallal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KLRS Kalaris Therapeutics, Inc. Director $15.6M Apr 10, 2025
SRRK Scholar Rock Holding Corp Director $2.73M Jun 27, 2024
SEER Seer, Inc. Director $722K Jun 12, 2024
ITOS iTeos Therapeutics, Inc. Director Jun 11, 2024

Insider Transactions Reported by David Hallal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.